Lili (Aurélie) Nsongo
Stock Analyst at Leerink Partners
(0.09)
# 4,838
Out of 5,133 analysts
42
Total ratings
15.2%
Success rate
-29.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lili (Aurélie) Nsongo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Therapeutics | Upgraded: Buy | $5 | $2.41 | +107.47% | 1 | Nov 13, 2026 | |
| IRD Opus Genetics | Rated: Buy | $14 → $15 | $3.98 | +276.88% | 3 | Oct 20, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $19 | $7.64 | +148.69% | 1 | Oct 12, 2026 | |
| VYGR Voyager Therapeutics | Reiterated: Buy | $11 | $1.73 | +535.84% | 11 | Dec 15, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $17 | $8.36 | n/a | 18 | Oct 23, 2025 | |
| EPA: ALSEN Sensorion SA | Reiterated: Buy | €3.00 | €8.44 | n/a | 8 | Sep 18, 2025 |
enGene Therapeutics
Nov 13, 2026
Upgraded: Buy
Price Target: $5
Current: $2.41
Upside: +107.47%
Opus Genetics
Oct 20, 2026
Rated: Buy
Price Target: $14 → $15
Current: $3.98
Upside: +276.88%
REGENXBIO
Oct 12, 2026
Reiterated: Buy
Price Target: $19
Current: $7.64
Upside: +148.69%
Voyager Therapeutics
Dec 15, 2025
Reiterated: Buy
Price Target: $11
Current: $1.73
Upside: +535.84%
Arcturus Therapeutics Holdings
Oct 23, 2025
Reiterated: Buy
Price Target: $17
Current: $8.36
Upside: n/a
Sensorion SA
Sep 18, 2025
Reiterated: Buy
Price Target: €3.00
Current: €8.44
Upside: n/a